Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23474655 | 0.95 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL23474682 | 0.94 | ALDH1A1 (0.45) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL23474663 | 0.93 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL23474689 | 0.92 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL21449238 | 0.90 | ALDH1A1 (0.45) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL24036850 | 0.88 | ALDH1A1 (0.52) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL22036067 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL17206528 | 0.87 | ALDH1A1 (0.51) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL21454432 | 0.86 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL20070560 | 0.86 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20210171510-A1 | COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | ALDH1A1 957/4885HPGD 3511/4885KDM4E 1227/4885 |
| US-20210171510-A1 | COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OCIAD1 | ALDH1A1 957/4885HPGD 3511/4885KDM4E 1227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.